Pediatric Cohort Study

NCT ID: NCT04561427

Last Updated: 2020-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-02-01

Study Completion Date

2022-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Narcolepsy is a rare disease that affects 0.05% of the general population. It is characterized by a dysregulation of the sleep wake regulation that leads to uncontrolled sleep episode during day and a disorganized sleep during night. These symptoms are due to a loss of hypocretin neurons in the brain leading to an inability to maintain wake properly. The physiopathology of this rare disease still needs investigations. Since we are a reference center for this disease, we propose to use patients files to better describe and document the sleep characteristics of these children, the cognitive performances, the effects of narcolepsy treatments on sleep architecture and the metabolic status of these children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Narcolepsy in Children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pediatric Patients with narcolepsy

* Patients between 0 and 18 years old
* Patients diagnosed with primary or secondary narcolepsy
* From both gender

Study of Sleep architecture in children with narcolepsy

Intervention Type OTHER

Evaluate the cognitive performances, the effects of narcolepsy treatments on sleep architecture and the metabolic status of these children

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Study of Sleep architecture in children with narcolepsy

Evaluate the cognitive performances, the effects of narcolepsy treatments on sleep architecture and the metabolic status of these children

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients between 0 and 18 years old
* Patients diagnosed with primary or secondary narcolepsy
* From both gender

Exclusion Criteria

* Patients diagnosed with another sleep disorder
* Healthy patients
* Patients older than 18 years old
Minimum Eligible Age

0 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

: Sleep pediatric unit , Woman Mother Child Hospital, Hospices Civils de Lyon

Lyon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Patricia Franco

Role: CONTACT

4.27.85.60.52 ext. +33

Aurore Guyon

Role: CONTACT

4.27.85.52.47 ext. +33

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Patricia Franco

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

COSACM_2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Local Sleep in Idiopathic Hypersomnia
NCT06153615 NOT_YET_RECRUITING NA